Dataset Information
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Ontology highlight
ABSTRACT:
SUBMITTER: Heiblig M
PROVIDER: S-EPMC9412002 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
